Alpha 2.0
Login Register
» Articles » PMID: 26099449

Pharmacokinetics and Preliminary Safety of High Dose Linezolid for the Treatment of Gram-positive Bacterial Infections

Overview
Journal J Infect
Specialty Infectious Diseases
Date 2015 Jun 24
PMID 26099449
Citations 5
Authors
Belen Lopez-Garcia
Sonia Luque
Jason A Roberts
Santiago Grau
Affiliations
Soon will be listed here.
Citing Articles

Calculated parenteral initial treatment of bacterial infections: Bone and joint infections.

Vossen M, Gattringer R, Thalhammer F, Militz M, Hischebeth G GMS Infect Dis. 2020; 8:Doc10.

PMID: 32373435 PMC: 7186792. DOI: 10.3205/id000054.

Population Pharmacokinetics and Dosage Optimization of Linezolid in Patients with Liver Dysfunction.

Zhang S, Zhu Z, Chen Z, Li Y, Zou Y, Yan M Antimicrob Agents Chemother. 2020; 64(6).

PMID: 32253210 PMC: 7269467. DOI: 10.1128/AAC.00133-20.

Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones.

Roger C, Roberts J, Muller L Clin Pharmacokinet. 2017; 57(5):559-575.

PMID: 29063519 DOI: 10.1007/s40262-017-0601-x.

Antibiotic Distribution into Cerebrospinal Fluid: Can Dosing Safely Account for Drug and Disease Factors in the Treatment of Ventriculostomy-Associated Infections?.

Kumta N, Roberts J, Lipman J, Cotta M Clin Pharmacokinet. 2017; 57(4):439-454.

PMID: 28905331 DOI: 10.1007/s40262-017-0588-3.

Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections.

Ferrandez O, Urbina O, Grau S Drug Des Devel Ther. 2017; 11:65-82.

PMID: 28053508 PMC: 5191846. DOI: 10.2147/DDDT.S84667.